CDC

CDC

JSI

CDC

JSI

CDC

WHO

JSI

JSI

RTI International

CDC

PAHO

MMGH Consulting

UNICEF EACRO

MMGH Consulting

MMGH consulting

Please share the videos and slides, thanks

Before IARs are shared globally, Is there a validation process?

Thanks for the great overview. Considering the fast pace of rollout, and the real-time observation of many barriers and bottlenecks, is there any recommendation to take a more prospective and real-time approach to documenting challenges and responding to them?

To respond to the question on a validation process. There is no specific validation process in place. We encourage sharing of as much detail as possible for peer learning at the discretion of the country.

The only validation is at country level. Countries may wish to share full IAR reports and part of the reports (executive summaries). We will talk about it later in the webinar.

@Jessica: Sure, the IAR encourages both a retrospective look of the response and prospective look. The prospective look is through the identification of critical actiions for remediation and improvement measures (recommendations) for immediate (shorterm - quick fixes, quick wins), mid-term and long term action.... the mid/long term recommendations are more aligned with health systems strengthening and (country) capacity capacity building

No

Countries will most likely need assistance to apply the IAR findings as quickly and seamlessly as possible for mid-course adjustments. Often, PIEs have been perceived as 'externally driven' and then 1-2 years after introduction, there are no resources to address gaps. We have a much compressed timeframe with COVID-19 vaccination, so how can we quickly resource implementation of IAR findings??

@LoraShimp. Perhaps we can address this in the discussion. Are you asking about resources in terms of funds for the follow up activities?

here is the link to the Global Fund COVID-19 response funding mechanism https://www.theglobalfund.org/en/covid-19/response-mechanism/

@Jenny - Yes, human, financial and operational resources to implement actions based on the IAR and mini-PIEs. We often raise the issues but then countries have insufficient resources to follow-up. We know with other NVIs, that sometimes VIG funds can be used for 1-2 years post-launch. What resources are available for C-19 vaccination to implement operational adjustments?

Please share the slides of Botswana IAR with us

Not every country is GF/GAVI is eligible

Not eligible

I am WCO

IAR and COVID-19 vaccination IAR (mini-cPIE) are country-owned and country-led process, so countries can decide how they decide to plan their mini-cPIEs

Countries should tailor the tools provided to their specific contexts

There are many partner organizations that are ,interested to support the IAR conduct and post-IAR follow up including the implementation of recommendations. those partners include Resolve to Save Lives (RTSL), CDC...

Please do not hesitate to reach out to us when and if you plan to conduct the mini-cPIE. We will be more than happy to support and advice on funding sources.

In terms of resources for country implementation/follow-up, we at WHO plan to coordinate among interested partners who plan to support countries. We are compiling a list of country plans for mini and classic PIEs

Given the "lite" nature of the IAR (1/2 to 2-3 days), the number of questions must be limited, especially if root cause analysis is to be done well. While new issues will need to be addressed as they emerge, what is the guidance to countries regarding tracking the same questions over time to monitor progress? This runs up against time constraints.

Thanks! Perhaps we can have a follow-up session on how countries like Botswana and other, larger LICs have resourced implementation post-IAR/mini-PIE?

Thanks and good weekend!

Merci a toutes et a tous